Development of innovative antimicrobials against pathogens resistant to antimicrobials[E8]

Do aviso

Call: Cluster 1 - Health (Single stage - 2027/1). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: The scientific and clinical communities have a better understanding of and access to new and innovative products for the treatment of antimicrobial resistant bacteria and fungi, as well as for further clinical investigation. Candidate therapies are available to treat patients for antimicrobial resistant bacteria and fungi, increasing therapeutic options for clinical deployment in the fight against Antimicrobial Resistance (AMR). Scope: The rapid rise of AMR presents a formidable threat to public health, challenging our ability to treat infections that were once easily managed with standard antimicrobials. As pathogens continually adapt and develop resistance to existing drugs, the efficacy of these treatments diminishes, leading to more severe and prolonged illnesses, increased healthcare costs and productivity losses, and higher mortality rates. This escalating crisis underscores an urgent need for viable therapeutic alternatives required to reduce the burden of diseases caused by antibiotic resistance. Innovative solutions are crucial to maintaining effective disease management and safeguarding public health. Propos…[E3]

Os detalhes do aviso aparecem como a fonte publicou. Os fatos e requisitos que extraímos estão em inglês.

• Aberto aUniversities and research. Classificado pelo SLETOR a partir das palavras do edital.
• CondiçãoEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

• RiscoThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
• DesconhecidoWe read the funder's listing, not the full guidance or application forms.

1. Aberta a propostas · 29 de out. de 2026, 07:41 UTC

   The funder published the call with a future closing date.

   Alterado: status, notice type, published at (registro de origem Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08))

2. Vista pela primeira vez · 28 de out. de 2026, 21:22 UTC

   The funder announced the call. Applications have not opened yet.

   Registro de origem: Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08)

Cada dado desta página vem do edital do financiador. Cada item mostra o registro e o campo de onde foi lido.

1. E1

   The funder is European Commission.

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/type/0, lido 29 de out. de 2026, 07:41 UTC · fonte ↗ (abre em nova aba)

2. E2

   Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

   “2027-02-17T00:00:00.000+0000”

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/deadlineDate/0, lido 29 de out. de 2026, 07:41 UTC · fonte ↗ (abre em nova aba)

3. E3

   The buyer describes the requirement in the notice.

   “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed…”

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/descriptionByte/0, lido 29 de out. de 2026, 07:41 UTC · fonte ↗ (abre em nova aba)

4. E4

   EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

   “EU call topic”

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/type/0, lido 29 de out. de 2026, 07:41 UTC · fonte ↗ (abre em nova aba)

5. E5

   This is an EU call for proposals.

   “31094502”

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/status/0, lido 29 de out. de 2026, 07:41 UTC · fonte ↗ (abre em nova aba)

6. E6

   Applications open on 29 Oct 2026.

   “2026-10-29T00:00:00.000+0000”

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/startDate/0, lido 29 de out. de 2026, 07:41 UTC · fonte ↗ (abre em nova aba)

7. E7

   The Funding & Tenders Portal gives the status as open for submission.

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/status/0, lido 29 de out. de 2026, 07:41 UTC · fonte ↗ (abre em nova aba)

8. E8

   The notice is titled "Development of innovative antimicrobials against pathogens resistant to antimicrobials".

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/title/0, lido 29 de out. de 2026, 07:41 UTC · fonte ↗ (abre em nova aba)

9. E9

   The EU contribution per grant is up to EUR 11,000,000 (from EUR 3,000,000).

   De Development of innovative antimicrobials against pathogens resistant to antimic… (ID HORIZON-HLTH-2027-01-DISEASE-08), campo /metadata/budgetOverview/0, lido 29 de out. de 2026, 07:41 UTC · fonte ↗ (abre em nova aba)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Licença dos dados: Creative Commons Attribution 4.0 (European Commission) ↗ (abre em nova aba). Dados de contato pessoais dos avisos não são guardados nem exibidos.